With another day of trading penny stocks and blue chips here and in full effect, there is a lot for investors to keep track of.
With penny stocks, we see that speculation is typically very high.
In early-morning trading, the Dow Jones Industrial Average Futures had dropped lower by around 260 points, with the S&P 500 down by around 1%.
This makes sense, however, given the less than stellar end of year we saw in 2021.
And the bulk of this relates to the pandemic and what occurs with case numbers in the near future.
While the market is no longer as tied to the number of cases, the after-effects of the pandemic are beginning to set in.
The big news for SRGA stock comes as the company announced that it had received FDA clearance for its HOLO Portal System.
The company stated that it has received Fast Track Designation from the FDA for this therapy in the treatment of advanced gastroesophageal junction cancers.
Similar to the other two penny stocks on this list, Polarityte announced that it received FDA approval for an IND regarding its Pivotal Phase 3 Study of SkinTE.
. The deal will offer a $200 million private placement of Sema4 Class A shares from several institutional investors including Pfizer.
patent #11,224,611 ‘Immune modulation with TLR9 agonists for cancer treatment.’ Patents are always a major deal with biotech companies as they give the company a clear pathway to move forward.